Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.84

+2.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (14374)	2/6/1998 5:03:00 PM
From: Arthur Radley	Read Replies (1) of 32384

Just received my current edition of WORTH magazine and more positive coverage on Ligand. Special feature section quotes Jim McCamant and his Medical Technology Stock Letter: "Ligand is now filing for FDA approval of its first product, a treatment for KS, and THREE MORE DRUGS WILL BE FILED FOR APPROVAL in the next two years. In all, Ligand has more than 30 products in development, some of which target multibillion-dollar markets. Ligand also has seven attractive partnerships; the latest is a $174 million blockbuster deal with Lilly for treating metabolic diseases. Add it all together and the company is well positioned to be one of the few profitable biotechs in 1999." McCamant recommends buying up to $16.00.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next